Skip to main content
. 2019 Sep 18;6:300. doi: 10.3389/fvets.2019.00300

Figure 5.

Figure 5

Expression of the apoptotic protein Bcl-2 (A) and Bax (B) in CTVT dogs before treatment (wk0) and during treatment (wk1–2 PT). BCL-2 expression (VCR) in wk 2 lower than wk0 significantly. Moreover, BAX expression (VCR-LAP) after treatment lower than before treatment significantly [Friedman repeated measures analysis of variance and Wilcox Signed-Rank test was used to determine the significance of differentiation before (wk0) and during treatment (wk1 and wk2) in each group, *p < 0.05]. BAX protein expression of the VCR-LAP protocol was significantly higher than the VCR protocol at wk2-PT (Mann-Whitney U-test was used to determine the significance of differentiation between the conventional and modified combination chemotherapeutic protocols, ap < 0.05).